Thyroid Stimulating Hormone [EPC]

1038 reported adverse events

Drugs of this class: 1,4-BENZOQUINONE - ARNICA MONTANA - OXYTOCIN - BARIUM CARBONATE - BARIUM OXALOSUCCINATE - CORTICOTROPIN - LEAD - LEVOTHYROXINE - LUTRELIN - MALIC ACID - MELATONIN - NEUROTROPHIN-3 - NEUROTROPHIN-4 - PHENYLALANINE - PORK LIVER - PYRUVIC ACID - RINFABATE - SUS SCROFA ADRENAL GLAND - SUS SCROFA FRONTAL LOBE - SUS SCROFA HYPOTHALAMUS - THYROTROPIN ALFA - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN - BETAINE - BUFO BUFO CUTANEOUS GLAND - CALCIUM CARBONATE - CHROMIC SULFATE - CICUTA VIROSA ROOT - COPPER - FOLIC ACID - GOLD - COBALAMIN - IRON - LACHESIS MUTA VENOM - MELATONIN - MOLYBDENUM - NEUROTROPHIN-3 - NEUROTROPHIN-4 - OXYTOCIN - SILICON DIOXIDE - SUS SCROFA FRONTAL LOBE - SUS SCROFA TEMPORAL LOBE - THYROTROPIN ALFA - UBIDECARENONE - VANADIUM - ZINC - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN - THYROTROPIN ALFA

These side effects are most commonly reported by patients taking drugs of the Thyroid Stimulating Hormone [EPC] class:

# Side effect Count
0 NAUSEA 130
1 HEADACHE 83
2 FATIGUE 82
3 OFF LABEL USE 81
4 VOMITING 53
5 MALAISE 43
6 DIZZINESS 41
7 PAIN 41
8 DRUG INEFFECTIVE 38
9 BLOOD THYROID STIMULATING HORMONE DECREASED 28
See all common reactions for Thyroid Stimulating Hormone [EPC]

Drugs of the Thyroid Stimulating Hormone [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD THYROID STIMULATING HORMONE DECREASED 28 0.0062
1 THYROID MASS 12 0.0031
2 DRUG ADMINISTERED AT INAPPROPRIATE SITE 23 0.0022
3 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
4 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 21 0.0011
5 BLOOD CALCIUM DECREASED 12 0.0011
6 THYROID CANCER 11 0.0009
7 HYPERTHYROIDISM 11 0.0008
8 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
9 PRODUCT PREPARATION ERROR 12 0.0006
See all enriched reactions for Thyroid Stimulating Hormone [EPC]